The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.

Dasmahapatra G, Lembersky D, Kramer L, Fisher RI, Friedberg J, Dent P, Grant S

Open source

DOI
10.1182/blood-2009-12-257261
Published
2010 Jun 3
Container
Blood
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood-2009-12-257261,
  title = {The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.},
  author = {Dasmahapatra G and Lembersky D and Kramer L and Fisher RI and Friedberg J and Dent P and Grant S},
  year = {2010},
  journal = {Blood},
  doi = {10.1182/blood-2009-12-257261},
  url = {https://doi.org/10.1182/blood-2009-12-257261}
}

RIS

TY  - JOUR
TI  - The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.
AU  - Dasmahapatra G
AU  - Lembersky D
AU  - Kramer L
AU  - Fisher RI
AU  - Friedberg J
AU  - Dent P
AU  - Grant S
PY  - 2010
JO  - Blood
DO  - 10.1182/blood-2009-12-257261
UR  - https://doi.org/10.1182/blood-2009-12-257261
ER  - 

APA

G, D., D, L., L, K., RI, F., J, F., P, D., & S, G. (2010). The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.. Blood. https://doi.org/10.1182/blood-2009-12-257261

Source records